SOLLUS THERAPEUTICS, INC.: Enhancing antigen sensitivity of BCMA CAR T cells for durable clinical responses inmultiple myeloma
SOLLUS THERAPEUTICS, INC. (Chapel Hill, North Carolina): Enhancing antigen sensitivity of BCMA CAR T cells for durable clinical responses inmultiple myeloma. Its award of $373,452 is below the median of $407,048 (46th percentile). Dated 58 days ago, it serves as a historical benchmark. Score 40/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).
Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)
award: $373,452 · 46th percentile of 10,712 NihBiotechGrantPulse records · 0.9x the median
Free preview: all 10 published fields of this record are shown below. Locked: 453 related NC NihBiotechGrantPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Organization | SOLLUS THERAPEUTICS, INC. |
| Location | CHAPEL HILL, NC |
| Project | Enhancing antigen sensitivity of BCMA CAR T cells for durable clinical responses inmultiple myeloma |
| Project number | 1R41CA310458-01A1 |
| Mechanism | R41 |
| Institute | National Cancer Institute |
| Award | $373,452 |
| Awarded | 2026-09-07 |
| Project period | 2026-09-07 to 2027-08-31 |
| UEI | L6W7MCAYEBE3 |
| award percentile | 46th of 10,712 (median $407,048, 0.9x median) |
| Peer records CSV (454 NC records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch SOLLUS THERAPEUTICS, INC.
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of NC records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock SOLLUS THERAPEUTICS + all 454 NC records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL
- Source agency: NIH RePORTER (newly awarded projects)
- Record date: 2026-09-07
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top NihBiotechGrantPulse records (NC first): RESEARCH TRIANGLE INSTITUTE · DUKE UNIVERSITY · WAKE FOREST UNIVERSITY HEALTH SCIENCES · UNIV OF NORTH CAROLINA CHAPEL HILL · DUKE UNIVERSITY · Browse all by state and category →
LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: SOLLUS THERAPEUTICS, INC. and 454 North Carolina peers
- North Carolina NihBiotechGrantPulse records like this one: 454
- SOLLUS THERAPEUTICS, INC.'s award: 46th percentile of 10,712 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every North Carolina peer: $90,800 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
40 / 100 Lab Budget Score
- Award of $373,452.
- Research or center grant: supplies, instruments and services budget.
What is the NihBiotechGrantPulse record for SOLLUS THERAPEUTICS, INC. in Chapel Hill, North Carolina?
SOLLUS THERAPEUTICS, INC. received an NIH award of $373,452 on 2026-09-07: Enhancing antigen sensitivity of BCMA CAR T cells for durable clinical responses inmultiple myeloma.
How does SOLLUS THERAPEUTICS, INC. compare to other North Carolina NihBiotechGrantPulse records?
Its award of $373,452 is below the median (46th percentile); smaller records often move faster and face less competition. It is 58 days old; check the official source for later updates before acting.
SOLLUS THERAPEUTICS, INC. vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| SOLLUS THERAPEUTICS, INC. | CHAPEL HILL, NC | 373,452 | 46th | 2026-09-07 |
| OPUS GENETICS INC. | RALEIGH, NC | 1,004,925 | 87th | 2026-09-19 |
| OPUS GENETICS INC. | RALEIGH, NC | 1,012,469 | 87th | 2026-09-17 |
| DUKE UNIVERSITY | DURHAM, NC | 1,038,700 | 88th | 2026-09-25 |
Related records
NihBiotechGrantPulse: records in North Carolina NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)
More North Carolina public-record feeds
Largest U.S. Greenhouse Gas Emitters by Company, Sector & State (EPA GHGRP) in North Carolina Nursing Home Inspection Deficiencies by State & Severity in North Carolina Federal Alcohol Permit Holder Directory in North Carolina New Grants by Vendor Procurement Need in North Carolina School & Library E-Rate Contracts Up for Rebid in North Carolina Newly CLIA-Certified Laboratories by State & Certificate in North Carolina Newly Posted IRS Automatic Revocations of Tax Exemption in North Carolina New SBA 7(a) & 504 Loan Approvals in North Carolina
How to monitor SOLLUS THERAPEUTICS, INC. and peer small business sbir/sttr (r41-r44, u43-u44) records
Get new NihBiotechGrantPulse records like SOLLUS THERAPEUTICS, INC. by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get newly funded labs in your territory
NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.